Clinical features, demography and predictors of outcomes of SARS-CoV-2 infection in a tertiary care hospital in India - a cohort study
Elavarasi et al.,
Clinical features, demography and predictors of outcomes of SARS-CoV-2 infection in a tertiary care hospital..,
medRxiv, doi:10.1101/2021.08.10.21261855 (Preprint)
Retrospective 2017 hospitalized patients in India, showing lower mortality with zinc treatment.
risk of death, 65.1% lower, RR 0.35, p < 0.001, treatment 486, control 1,201, adjusted per study, odds ratio converted to relative risk, model 4, multivariate logistic regression, control prevalence approximated with overall prevalence.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Elavarasi et al., 12 Aug 2021, retrospective, India, preprint, 26 authors.
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2021.08.10.21261855; this version posted August 12, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.
Title page
Clinical features, demography and
predictors of outcomes of SARS-CoV-2
infection in a tertiary care hospital in
India-A cohort study
Arunmozhimaran Elavarasi1*; Hari Krishna Raju Sagiraju2*; Rohit Kumar Garg;3 Brajesh Ratre;4 Prashant
Sirohiya; 4 Nishkarsh Gupta; 4 Rakesh Garg;4 Anuja Pandit;4 Saurabh Vig;4 Ram Nalwa;4 Balbir Kumar;4 Ved
Prakash Meena; 3 Naveet Wig; 3 Saurabh Mittal;5Saurabh Pahuja;5 Karan Madan5; Randeep Guleria; 5
Anant Mohan; 5 Tanima Dwivedi;6Ritu Gupta;6 Ashima Jain Vidyarthi;7 Laxmitej Wundawalli;8 Angel Rajan
Singh;8 Sheetal Singh; 8 Sunil Kumar;9 Sushma Bhatnagar4#
*Equal contributorship
1 Department of Neurology, All India Institute of Medical Sciences, New Delhi
2 Department of Preventive Oncology, All India Institute of Medical Sciences, New Delhi
3 Department of Medicine, All India Institute of Medical Sciences, New Delhi
4 Department of Onco-anesthesia and Palliative Medicine, All India Institute of Medical Sciences, New
Delhi
5 Department of Pulmonary medicine, critical care and Sleep disorders, All India Institute of Medical
Sciences, New Delhi
6 Department of Laboratory Oncology, All India Institute of Medical Sciences, New Delhi
7 Department of Microbiology, All India Institute of Medical Sciences, New Delhi
8 Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi
9 Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi
#Corresponding Author
Prof Sushma Bhatnagar
Head, Department of Onco-anesthesia and Palliative care
All India Institute of Medical Sciences, New Delhi
sushmabhatnagar1@gmail.com
Mobile:- +91-9811326453
Number of words: 3195
Number of tables: 6
Number of supplementary tables: 2
Number of references: 14
Number of figures: 2
Conflicts of interest: None of the authors report any conflict of interest
Funding: No funding was obtained
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
medRxiv preprint doi: https://doi.org/10.1101/2021.08.10.21261855; this version posted August 12, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.
Contributorship statement
•
•
•
•
•
•
•
•
•
•
•
•
•
Arunmozhimaran Elavarasi was involved in the conceptualization of the study, study design,
patient care, data collection, statistical analysis, and in writing the first draft of the manuscript
Hari Krishna Raju Sagiraju was involved in the conceptualization of the study, study design,
patient care, data collection, statistical analysis, and critique of the manuscript
Rohit Kumar Garg was involved in the conceptualization of the study, study design, patient care
and in the critique of the manuscript
Brajesh Ratre, Prashant Sirohiya, Nishkarsh Gupta, Rakesh Garg, Anuja Pandit, Saurabh Vig, Ram
Nalwa, Balbir Kumar were involved in study design, patient care and in the critique of the
manuscript
Ved Prakash Meena was involved in the study..
Late treatment
is less effective
elavarasi
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit